| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
895 |
855 |
$51K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
660 |
523 |
$20K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
174 |
167 |
$17K |
| 99173 |
|
553 |
553 |
$12K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
126 |
126 |
$12K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
1,184 |
1,177 |
$11K |
| 96127 |
|
710 |
710 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
115 |
113 |
$6K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
127 |
123 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
26 |
26 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
75 |
75 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
134 |
133 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
14 |
14 |
$1K |
| 0071A |
|
20 |
20 |
$800.00 |
| 0072A |
|
17 |
17 |
$779.96 |
| 90461 |
|
12 |
12 |
$413.28 |
| 99051 |
|
12 |
12 |
$198.72 |